Source: Annual Congress 2002 - Cystic fibrosis: new science, new epidemiology, new problems



Rating:

Share or cite this content

Citations should be made in the following way:
E. N. Mitkina, T. E. Gembitskaia, M. A. Zaitseva, L. A. Jelenina, T. S. Sologub (St-Petersburg, Russia). Analysis of relationship between Nasal Potential Difference, genotype and clinical phenotype in patients with cystic fibrosis. Eur Respir J 2002; 20: Suppl. 38, 2120

Member's Comments

No comment yet.

Related content which might interest you: Nasal potential difference measurements in patients with atypical cystic fibrosis Source: Eur Respir J 2001; 17: 1208-1215 Year: 2001 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Response to isoprenaline at nasal potential difference measurement and clinical variability in ΔF508 homozygote Cystic Fibrosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Potential difference test is valuable in the diagnosis of cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 Relationship between nutritional and clinical status in adult cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 58s Year: 2006 Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Phenotype and genotype in adult patients with cystic fibrosis in Uruguay Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 Inflammation in cystic fibrosis patients: study of the eicosanoid pathway and severity correlations. Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Nasal potential difference (NPD) in cystic fibrosis (CF) and non-CF patients with borderline sweat test Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001 Single-breath washout and association with structural lung changes in children with cystic fibrosis Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016 Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002 Genotype specific therapies for cystic fibrosis Source: Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies Year: 2004